山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (1): 83-87.doi: 10.6040/j.issn.1673-3770.0.2015.341

• 论著 • 上一篇    下一篇

糖尿病患者行白内障超声乳化术后视力及眼底的变化

邵娜1,张晗2   

  1. 1.济宁市第一人民医院眼科, 山东 济宁 272000;
    2.山东大学第二医院眼科, 山东 济南 250033
  • 收稿日期:2015-08-16 出版日期:2016-02-16 发布日期:2016-02-16
  • 通讯作者: 张晗. E-mail:zhanghan9157@gmail.com E-mail:shaonalady@163.co
  • 作者简介:邵娜. E-mail:shaonalady@163.co

Variation of visual acuity and fundus in type 2 diabetic patients after phacoemulsification surgery.

SHAO Na1, ZHANG Han   

  1. Department of Ophthalmology, 1. Jining No.1 Peoples Hospital, Jining 272000, Shandong, China;2. The Second Hospital of Shandong University, Jinan 250033, Shangdong, China
  • Received:2015-08-16 Online:2016-02-16 Published:2016-02-16

PDF (PC)

822

被引次数

1

摘要： 目的 通过观察2型糖尿病患者行白内障超声乳化摘除及人工晶体植入术后视力及眼底的变化以评估糖尿病视网膜病变(DR)进展的相关危险因素。 方法 选取50例2型糖尿病伴非增殖型糖尿病视网膜病变(NPDR)且需单眼行白内障超声乳化及人工晶体植入术患者为研究对象,手术眼为手术组,非手术眼为非手术组。术后1、7 d及1、3个月,分别行最佳矫正视力(BCVA)及黄斑区光学相干断层扫描(OCT);术后3个月行FFA检查,分析DR进展的相关危险因素。 结果 手术组术后1 d~3个月视力明显改善(P<0.01),术后3个月BCVA呈下降趋势。手术组术后黄斑水肿发生率及DR进展率明显高于非手术组,差异有统计学意义(P<0.05或P<0.01)。Logistic回归分析结果显示,糖化血红蛋白(HbA1c)(OR=21.423)、糖尿病病程(OR=9.061)、NPDR程度(OR=2.486)为DR进展的危险因素。 结论 2型糖尿病NPDR患者行超声乳化及人工晶体植入术后BCVA明显改善,于术后3个月呈轻微下降趋势。糖尿病病程长、血糖控制差、术前DR加重是术后DR进展的危险因素。

关键词: 糖尿病视网膜病变, 光学相干断层扫描, 2型糖尿病, 超声乳化, 最佳矫正视力

Abstract: Objective To evaluate the risk factors of diabetic retinopathy(DR)progression by observing the variation of visual acuity and fundus in type 2 diabetic patients after phacoemulsification and intraocular lens implantation. Methods A total of 50 patients with type 2 diabetes mellitus accompanied by non-proloferative diabetic retinopathy(NPDR)who needed to undergo phacoemulsification and intraocular lens implantation for the single eye were collected as research objects. Operative eyes and non-operatives were respectively as surgery and non-surgery groups. On 1, 7 days and 1, 3 months after surgery, both the best corrected visual acuity(BCVA)and optical coherence tomography(OCT)in macular region were conducted, and fundus fluorescein angiography(FFA)was also performed 3 months after surgery. The DR progression-related risk factors were analyzed. Results The visual acuity in surgery group improved obviously 1 d-3 months after surgery(P<0.01), but BCVA 3 months after surgery had the decreasing trend. The incidence of postoperative macular edema and DR progression rate in surgery group were higher than in non-surgery group, with statistical significance(P<0.05 or P<0.01). Logistic regression analysis research results displayed that glycosylated hemoglobin(OR=21.423), course of diabetes mellitus(OR=9.061)and NPDR degree(OR=2.486)were the risk factors of DR progression. Conclusion The BCVA of patients with NPDR in type 2 diabetes mellitus improves dramatically after phacoemulsification and intraocular lens implantation, but decreases slightly 3 months after surgery. Long course of diabetes mellitus, worse control of blood glucose and preoperative aggravation of DR are the risk factors of postoperative DR progression.

Key words: Type 2 diabetes mellitus, Phacoemulsification, Optical coherence tomography, Best corrected visual acuity, Diabetic retinopathy

中图分类号: 

  • R776.1
[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国医学前沿杂志(电子版), 2011, 3(6): 54-109.
[2] 刘巨平, 胡博杰, 程朝晖, 等. 白内障超声乳化吸除术对糖尿病视网膜病变进展影响的Meta分析[J]. 眼科, 2013, 22(6):378-382. LIU Juping, HU Bojie, CHENG Zhaohui, et al. The influence of cataract phacoemulsification on progression of diabetic retinopathy and diabetic macular Meta-analysis[J]. Ophthalmol, 2013, 22(6):378-382.
[3] Ostri C. Intraocular surgery in a large diabetes patient population: risk factors and surgical results[J]. Acta Ophthalmol, 2014, 92(Thesis1):1-13.
[4] Lara-Smalling A, Cakiner-Egilmez T. Diabetes and cataract surgery: preoperative risk factors and positive nursing interventions[J]. Insight, 2014, 39(2):18-20.
[5] Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery[J]. Ophthalmol, 1996, 80(9):789-793.
[6] Varma R, Macias G L, Torres M, et al. Biologic risk factors associated with diabetic retinopathy[J]. Ophthalmol, 2007, 7:1332-1340.
[7] 谢茂松, 郑永征, 徐国兴. 眼前节内眼模拟手术诱发血眼屏障破坏的大鼠动物模型[J]. 中华眼底病杂志, 2012, 28(1):68-72. XIE Maosong, ZHENG Yongzheng, XU Guoxing. Rat model of blood-ocular barrier breakdown induced by anterior segment intraocular analogic surgery[J]. Chin J Ocul Fund Dis, 2012, 28(1):68-72.
[8] 周媛, 崔浩, 刘洪涛, 等. 糖尿病对血-视网膜屏障超微结构影响的研究进展[J]. 国际眼科杂志, 2014, 7(7):1220-1222. ZHOU Yuan, CUI Hao, LIU Hongtao, et al. Research progress of diabetes on the ultrastructure of blood retina barrier[J]. Inter Eye Sci, 2014, 14(7):1220-1222.
[1] 王新萌,姬俊雅,于浩南,付鸿臣,王翔,郑泽坤,李艳,钟莹莹. 急性闭角型青光眼超声乳化联合房角分离术后屈光预测准确性分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 74-79.
[2] 赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[3] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[4] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[5] 李世强,马燕,王家伟. 光学相干断层扫描血管成像在全身疾病中的临床应用研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 127-134.
[6] 黄娇,彭昌福. 甲状腺相关性眼病活动性客观评价的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 171-178.
[7] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[8] 常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136.
[9] 何静,雷春燕,张美霞. 糖化血红蛋白变异指数与糖尿病视网膜病变严重程度的相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 34-40.
[10] 吴丽丽,曲毅. OCTA在病理性近视脉络膜新生血管应用及其在人工智能的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 144-149.
[11] 王新钰,高丽芬,路晖,宋文琦,杨钰. 帕金森疾病的相关视网膜表现[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 156-162.
[12] 伦英俊,陈晨,高宏程,范清琳,邰仁清. TLR4/NF-κB通道在糖尿病视网膜病变中的作用[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 163-168.
[13] 刘江川,李鹏伟,郭建强,陆慧琴. 光学相干断层扫描成像在特发性视网膜前膜中的应用研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 138-142.
[14] 买尔哈巴·玉素甫,克里木江·阿不拉,丁琳,秦艳莉,陈雪艺. 伴发于后巩膜葡萄肿的高度近视性白内障眼底病变相关研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 107-114.
[15] 张晓晗,魏丽,杨凯莉,陈海燕,李彦松,王平. 中医辨证论治前后CSC患者OCTA变化及其与视力的相关性研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 115-122.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发